Mepolizumab (Nucala)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 19:47, 27 February 2020 by Warner-admin (talk | contribs) (Text replacement - "Category:Antibody medications" to "")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).

Diseases for which it is used

History of changes in FDA indication

No approval for hematology/oncology conditions, at this time.

Also known as

  • Brand names: Bosatria, Nucala
Retrieved from "https://hemonc.org/w/index.php?title=Mepolizumab_(Nucala)&oldid=43364"